Outpatient withdrawal management is designed for individuals assessed as having low-to-moderate risk for severe or life-threatening alcohol withdrawal symptoms.

During your initial clinical evaluation, an addiction medicine provider evaluates your drinking history, past withdrawal experiences, medical co-morbidities, and current vitals:

• Mild to Moderate Risk: Eligible for outpatient withdrawal management at Ideal Option, utilizing prescribed medications (such as gabapentin or short-term benzodiazepines) alongside close medical monitoring.
• High Risk / Severe Withdrawal: Patients showing signs of severe withdrawal risk are immediately referred to an inpatient medically managed detoxification facility. Once inpatient withdrawal is complete, patients return to Ideal Option for long-term outpatient relapse prevention.

Ideal Option typically offers same-day or next-day appointments to start AUD treatment as soon as you are ready.

Initial appointment logistics include:

• Transportation Requirement: If you are currently drinking, you must arrange for a responsible adult driver to transport you to and from the clinic. If you arrive over the legal blood alcohol limit, clinic policy prohibits driving yourself home.
• Telehealth Options: Remote intake assessments are available in select states, though an in-clinic visit for a Blood Alcohol Content (BAC) test is required within a few days of starting medication (state laws, such as in Arkansas, require all visits to take place in-clinic).

Appointment frequency begins with frequent visits during withdrawal management and transitions to monthly check-ins once stability is achieved.

The typical progression follows three stages:

1. Withdrawal Phase (Weeks 1–2): Frequent in-clinic or remote check-ins as needed to evaluate withdrawal severity, check vitals, and adjust medications.
2. Stabilization Phase (Weeks 3–6): Weekly to bi-weekly visits to monitor craving reduction and transition to relapse-prevention medications.
3. Maintenance Phase (Long-Term): Monthly visits for ongoing prescription management, routine lab monitoring, and behavioral health referrals.

Targeted breathalyzer and urine toxicology tests ensure patient safety when prescribing medications and help track recovery progress over time.

Breathalyzer and laboratory tests allow providers to:

• Accurately measure Blood Alcohol Content (BAC) before administering or prescribing withdrawal management medications.
• Prevent dangerous drug interactions between alcohol, prescribed treatments, and other CNS depressants.
• Adjust treatment plans dynamically based on objective biological markers rather than punishment or penalization.

Ideal Option diagnoses Alcohol Use Disorder using the standardized Diagnostic and Statistical Manual of Mental Disorders (DSM-5) clinical criteria.

A diagnosis of AUD is confirmed if a patient meets two or more of the 11 established DSM-5 criteria within a 12-month period. Severity is categorized based on the number of symptoms met:

• Mild AUD: 2 to 3 criteria met
• Moderate AUD: 4 to 5 criteria met
• Severe AUD: 6 or more criteria met

Evidence & Authoritative Reference: The National Institutes of Health (NIH) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) establish the DSM-5 benchmark to help clinicians accurately evaluate AUD severity and tailor pharmacotherapy to individual patient needs (NIH/NIAAA Alcohol Use Disorder Criteria).

If you engage in risky drinking but do not meet the criteria for alcohol use disorder, your provider will discuss whether reducing or abstaining from alcohol is the more appropriate goal. Your treatment goal will be somewhat dependent on factors such as a family history of alcohol problems, your age, and your history of traumatic events related to drinking.

Alcohol withdrawal syndrome can be severe and potentially fatal, so it is particularly important to identify when there is a need for inpatient medically-managed withdrawal. If you are assessed for severe withdrawal, you will be referred to an inpatient program that can provide medically monitored withdrawal management.

Most patients will taper off withdrawal medications in 5-10 days while medications used for relapse prevention may be prescribed indefinitely. Alcohol use disorder is a chronic relapsing disease, so persistence is key. For most people, continuing medication and regularly following up with a treatment provider is critical to preventing relapse and staying abstinent from alcohol over the long term. 

Reducing drinking may be an acceptable goal for some low risk patients. Our providers are trained on the Sinclair method if patients are interested in learning more about this non-FDA approved dosing approach. This method may be beneficial in some cases but overall we recommend using the most evidence-based treatment methods. 

None of the available medications are approved by the FDA for use in people younger than age 18 or proven safe for pregnant women. Younger adolescents and pregnant women in need of treatment will be referred to a clinician or program specializing in methods appropriate for those populations. 

If you are having a medical emergency during the withdrawal phase, it's essential that you are willing to call 911 or visit your local emergency room for immediate attention. We strongly recommend you have a responsible adult with you at all times during withdrawal phase to assist you as needed.

If you are having milder symptoms or have questions, please reach out to the Ideal Option Nurse Care Team at 1-877-522-1275. Our registered nurses are available 24 hours a day, 7 days a week to assist you over the phone.

Counseling is available through Ideal Option’s behavioral health organization (Ideal Balance) in select Washington State clinics.

Under state licensing requirements, patients must first see an Ideal Option addiction medicine provider before enrolling in counseling services.